1. Home
  2. WVVI vs TPST Comparison

WVVI vs TPST Comparison

Compare WVVI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVVI
  • TPST
  • Stock Information
  • Founded
  • WVVI 1983
  • TPST 2011
  • Country
  • WVVI United States
  • TPST United States
  • Employees
  • WVVI N/A
  • TPST N/A
  • Industry
  • WVVI Beverages (Production/Distribution)
  • TPST Biotechnology: Pharmaceutical Preparations
  • Sector
  • WVVI Consumer Staples
  • TPST Health Care
  • Exchange
  • WVVI Nasdaq
  • TPST Nasdaq
  • Market Cap
  • WVVI 28.2M
  • TPST 33.0M
  • IPO Year
  • WVVI N/A
  • TPST N/A
  • Fundamental
  • Price
  • WVVI $4.90
  • TPST $6.65
  • Analyst Decision
  • WVVI
  • TPST Hold
  • Analyst Count
  • WVVI 0
  • TPST 3
  • Target Price
  • WVVI N/A
  • TPST $30.00
  • AVG Volume (30 Days)
  • WVVI 26.0K
  • TPST 87.0K
  • Earning Date
  • WVVI 08-12-2025
  • TPST 08-07-2025
  • Dividend Yield
  • WVVI N/A
  • TPST N/A
  • EPS Growth
  • WVVI N/A
  • TPST N/A
  • EPS
  • WVVI N/A
  • TPST N/A
  • Revenue
  • WVVI $38,520,945.00
  • TPST N/A
  • Revenue This Year
  • WVVI N/A
  • TPST N/A
  • Revenue Next Year
  • WVVI N/A
  • TPST N/A
  • P/E Ratio
  • WVVI N/A
  • TPST N/A
  • Revenue Growth
  • WVVI N/A
  • TPST N/A
  • 52 Week Low
  • WVVI $3.17
  • TPST $5.35
  • 52 Week High
  • WVVI $7.18
  • TPST $30.03
  • Technical
  • Relative Strength Index (RSI)
  • WVVI 32.35
  • TPST 41.05
  • Support Level
  • WVVI $5.21
  • TPST $7.06
  • Resistance Level
  • WVVI $5.75
  • TPST $7.05
  • Average True Range (ATR)
  • WVVI 0.27
  • TPST 0.26
  • MACD
  • WVVI -0.04
  • TPST -0.05
  • Stochastic Oscillator
  • WVVI 0.00
  • TPST 0.11

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Share on Social Networks: